![]() |
|
|
Vol. 282, Issue 2, 671-675, 1997
Department of Anatomy and Developmental Biology, University College London, Gower Street, London, England
| |
Abstract |
|---|
|
|
|---|
Long-term interactions between sympathetic and sensory-motor nerves have been shown in several tissues. Previous investigations in this laboratory have demonstrated an increase in cardiac sensory-motor innervation after neonatal sympathectomy by guanethidine and an increase of perivascular sympathetic neurotransmission after neonatal treatment by capsaicin. The present study evaluated the effects of sensory-motor denervation on sympathetic neurotransmission in the heart. Newborn rats were injected with capsaicin or its vehicle (Tween 80). Sympathetic neurotransmission was studied in isolated atria driven at a constant rate (4 Hz) by measuring cardiac responses to electrical field stimulation, in the presence of atropine 1 µM. Inotropism of tyramine, norepinephrine and calcitonin gene-related peptide was also tested. Neonatal capsaicin treatment did not affect cardiac responses to trains of an increasing number (2-32) of field pulses. Moreover, inotropic responses to tyramine did not differ between control, capsaicin- and Tween 80-treated preparations. Neither maximal effect nor pD2 values were significantly different between the groups. Similarly, the inotropism of calcitonin gene-related peptide was comparable in all groups of atrial preparations. In marked contrast to earlier papers on blood vessels, this study shows a lack of effect of sensory-motor denervation by neonatal capsaicin treatment on cardiac sympathetic neurotransmission. The different neuronal plasticity of vascular and cardiac sensory innervation will be discussed. The present results also indicate that capsaicin-induced sensory-motor denervation is not associated with changes in cardiac responsiveness to calcitonin gene-related peptide.
| |
Introduction |
|---|
|
|
|---|
The
cardiovascular system is richly supplied by neuropeptide-containing
nerves (Wharton and Gulbenkian, 1987
; Mione et al., 1990
).
These include small-caliber unmyelinated sensory fibers (C, and A
fibers) sensitive to the neurotoxin capsaicin, that contribute to the
regulation of cardiac performance and vascular tone via
peripheral co-release of CGRP, SP and related neurokinins (Holzer,
1988
; Maggi and Meli, 1988
; Rubino and Burnstock, 1996
). Because of the
dual afferent and efferent function, the term sensory-motor nerves has been used to identify this neuronal population
(Burnstock, 1990
; Rubino and Burnstock, 1996
). In both cardiac and
perivascular sensory-motor neurotransmission, CGRP is the principal
active transmitter that interacts with specific receptors in the target organ. In the myocardium, sensory-motor neurotransmission evokes cardioexcitatory effects, including positive chronotropism and inotropism, associated with coronary vasodilatation (Saito et al., 1987
; Franco-Cereceda, 1991
), the cardioexcitatory effects of
CGRP being in several respects comparable to those of norepinephrine (Mantelli et al., 1991
; Rubino and Burnstock, 1996
).
Vasodilator responses to sensory-motor stimulation have been shown in
other vascular beds, including the mesenteric arterial tree (Kawasaki et al., 1988
; Rubino and Burnstock, 1996
).
Functional cross-talk between sympathetic and sensory-motor innervation
has been shown in the heart and the mesenteric vascular bed. The
sympathetic cotransmitters norepinephrine, neuropeptide Y and ATP
modulate sensory-motor neurotransmission in isolated guinea pig atria
and rat mesenteric vascular bed via prejunctional mechanisms
(Kawasaki et al., 1990
; Amerini et al., 1991
).
Long-term interactions have also been documented between these nerves.
Previous investigations in our laboratory have shown that long-term
sympathectomy by guanethidine in newborn rats evokes a selective
increase of CGRP-like immunoreactivity in several tissues, a striking
increase being observed in the atrial myocardium (Aberdeen et
al., 1990
, 1992
). On the other hand, sensory-motor denervation by
neonatal treatment with capsaicin increases perivascular sympathetic
neurotransmission in the rat mesenteric arterial bed via
both pre- and postjunctional mechanisms (Ralevic et al.,
1995a
). However, whether sensory-motor denervation has functionally
expressed effects in the peripheral control of cardiac contractility
remains to be established. Because sensory-motor nerves activate a
variety of reflex responses leading to peripheral discharge of
sympathetic and parasympathetic cardiac innervation, this information
would be an important contribution to understanding of the autonomic
control of cardiac function and would further elucidate the functional
cross-talk between different components of the autonomic innervation in
the heart.
The present study aimed therefore to evaluate the effects of
sensory-motor denervation on cardiac sympathetic neurotransmission. Newborn rats were treated with capsaicin to cause permanent disruption of sensory-motor nerves (Holzer, 1991
). Inotropic responses to EFS as
well as to tyramine and exogenous norepinephrine were evaluated in
atria isolated from rats treated with capsaicin or vehicle. The
inotropism of CGRP was also compared in control and capsaicin-treated preparations.
| |
Materials and Methods |
|---|
|
|
|---|
Capsaicin treatment.
Capsaicin treatment of newborn rats was
performed as described previously in order to obtain sensory-motor
denervation (Ralevic et al., 1995a
). Sprague-Dawley rats
were given s.c. injections of capsaicin (50 mg/kg b.wt.) on days 1, 2, 3, 5, 7 and 14 of life. Hypothermic anesthesia was used on the first
few days of treatment by placing the pups in ice until movements and
sensory perception were drastically reduced. Different litters were
injected with vehicle (10% Tween 80, 10% ethanol, 80% saline). A
third group of litters was used as age-matched controls. Tissue was obtained from these rats 12 to 14 weeks after capsaicin or vehicle injection. At the time of experimentation, body weight significantly differed among groups, being 607.3 ± 19.0 (n = 6), 550.7 ± 12.5 (n = 7) and 509.1 ± 13.8 g (n = 8) in control, Tween 80-treated and
capsaicin-treated rats, respectively. Success of the capsaicin treatment was confirmed by lack of inotropic responses in
vitro to capsaicin (1 µM).
Experimental preparation.
The experimental model was as
previously described (Rubino and Burnstock, 1995
). Briefly, atria were
isolated and mounted vertically in 10-ml organ baths containing
Tyrode's solution of the following composition (mM): NaCl 115; KCl
4.7; CaCl2 1.8; MgSO4 1.2;
KH2PO4 1.2; NaHCO3 25; glucose 10, oxygenated with 95% O2 and 5% CO2 and kept at
a constant temperature of 30°C, in order to reduce the metabolic need
of the tissue without affecting the contractile function of the
preparations, and in order to reduce the spontaneous atrial activity.
Atria were stretched until the maximal spontaneous contractility was
reached by applying a basal tension of 0.8 g. The atrial
preparations were then electrically driven at a constant rate (4 Hz)
throughout the experiment by punctuate electrodes connected with a
pulse generator (model S9, Grass Instrument Co., Quincy, MA). Isometric
contraction was recorded by an isometric force-displacement transducer
(model FT 03C, Grass Instrument Co., Quincy, MA) and a D.C.
preamplifier on a pen recorder (model 79D, Grass Instrument Co.,
Quincy, MA). Experiments were started after a period of equilibration
of at least 60 min. Cumulative concentration-effect curves for the
agonists tested were obtained at 20-min intervals. Because basal
contractile tension did not significantly differ among control,
capsaicin-treated and Tween 80-treated preparations, inotropic
responses to EFS and to the agonists tested were evaluated as
milligrams of increase above the basal contractile tension.
Sympathetic neurotransmission. Sympathetic neurotransmission was evaluated by EFS of the preparations. Trains of increasing numbers (2-32) of field pulses (20 Hz, 100-120 V, 1 ms) were applied at 3-min interval through two platinum plates parallel to the preparations and connected with a second pulse generator (model S45, Grass Instrument Co.). Atropine (1 µM) was present throughout the experiments in order to eliminate the parasympathetic response to EFS. Cardiac responses to EFS were almost abolished in the presence of the beta adrenoceptor blocker propranolol (1 µM) and were sensitive to 60-min treatment with guanethidine (50 µM), which confirmed that sympathetic neurotransmission was being evaluated.
Drugs.
Rat CGRP, 8-methyl-N-vanillyl-6-nonenamide
(capsaicin), (
)norepinephrine (arterenol bitartrate) and tyramine
hydrochloride were from Sigma Chemical Co. (St. Louis, MO).
(
)Propranolol (Inderal) was from ICI (Macclesfield, England), and
guanethidine (Ismelin) was from Ciba Laboratories (Horsham, England).
Reactive salts were from RBI.
Data evaluation.
Data are reported as mean values ± S.E.; n refers to the number of animals from which
experimental preparations were obtained. Analysis of data was performed
on an IBM personal computer using FigP and GBStat softwares. The
pD2 values were calculated from the concentration-response
curves constructed with the FigP software as
log concentration of
agonist giving 50% of the maximal effect. Group comparisons were made
by applying repeated-measures analysis of variance according to
Ludbrook (1994)
. Results were considered significantly different when
P < .05.
| |
Results |
|---|
|
|
|---|
Cardiac responses to EFS and tyramine.
Control preparations
developed a basal tension of 255.2 ± 32.3 mg (n = 6). Basal tension in capsaicin- and Tween 80-treated preparations did
not differ significantly, being 240.0 ± 25.8 (n = 9) and 219.6 ± 25.6 mg (n = 7), respectively. In
the presence of atropine 1 µM, EFS evoked positive inotropic
responses that increased with increasing number of field pulses in each
experimental group. However, no significant difference was shown
between control and capsaicin-treated preparations (fig.
1A). When the highest number of pulses
(32) was applied, cardiac contractile tension increased by 412.3 ± 59.1 (n = 4), 377.5 ± 93.5 (n = 7) and 318.0 ± 66.6 mg (n = 4) in control,
capsaicin-treated and Tween 80-treated preparations, respectively. In
order to test calcium-independent outflow of catecholamines from
sympathetic nerve terminals, we evaluated inotropic responses to the
sympathomimetic agonist tyramine. Increasing concentrations of tyramine
(0.3-10 µM) evoked positive inotropic responses that were not
significantly different among control, capsaicin-treated and Tween
80-treated preparations (fig. 1B).
|
Cardiac responses to norepinephrine, CGRP and calcium.
The
sympathetic neurotransmitter norepinephrine, applied exogenously at
concentrations of 1 to 300 nM, evoked similar increases of the
contractile tension in control, capsaicin-treated and Tween 80-treated
preparations (fig. 2A). Maximal inotropic
responses developed in the presence of norepinephrine 300 nM were
239.0 ± 29.7 (n = 5), 273.7 ± 27.6 (n = 7) and 307.0 ± 86.1 mg (n = 4) increases of the basal contractile tension in control,
capsaicin-treated and Tween 80-treated preparations, respectively. The
pD2 values were 7.49 ± 0.05 (n = 5),
7.26 ± 0.07 (n = 7) and 7.43 ± 0.07 (n = 4) in atria from control, capsaicin-treated and
Tween 80-treated animals, respectively.
|
| |
Discussion |
|---|
|
|
|---|
The high selectivity of capsaicin for sensory-motor nerves is now
well established (Holzer, 1988
, 1991
; Maggi and Meli, 1988
). The s.c.
administration of high doses of capsaicin in newborn rats has been
shown to cause, within 30 min, a permanent degeneration of unmyelinated
primary sensory fibers (Jancso et al., 1977
; Holzer, 1991
).
A drastic reduction in the content of CGRP- and SP-immunoreactivity has
been shown in the cardiovascular system after neonatal administration of capsaicin (Wimalawansa, 1993
). Therefore, in the present study, we
administered capsaicin to newborn rats in order to obtain sensory-motor denervation.
The results of the present investigation show that sensory-motor
denervation does not modify cardiac sympathetic neurotransmission. Cardiac responses to EFS and tyramine were unaffected by neonatal treatment with capsaicin, which indicates that mechanisms including both calcium-dependent exocytosis and calcium-independent release of
the sympathetic neurotransmitter norepinephrine were maintained. These
observations provide direct evidence for a lack of functional changes
in the sympathetic innervation of the myocardium after sensory-motor
denervation. The functional data of the present study are in line with
results showing unchanged levels of norepinephrine in atria and
superior cervical ganglion after capsaicin treatment of developing rats
(Luthman et al., 1989
). Lack of functionally expressed
changes in sympathetic innervation were also shown in the rat tarsal
muscle (Fike et al., 1992
). In contrast, a significant increase of norepinephrine levels was shown in the vasculature of iris,
cornea and oral cavity after sensory denervation (Terenghi et
al., 1986
; Luthman et al., 1989
). Similarly, in the rat
mesenteric arterial bed, sympathetic neurotransmission was enhanced by
neonatal treatment with capsaicin as a consequence of increased tissue levels of norepinephrine (prejunctional changes) and
hyper-responsiveness to the exogenous neurotransmitter (postjunctional
changes; Ralevic et al., 1995a
). In the present study of the
heart, inotropic responses to norepinephrine did not differ between
control and treated tissues, a result that indicates a lack of
postjunctional changes in cardiac sympathetic neurotransmission because
of sensory-motor denervation.
Long-term interactions between the peripheral terminals of sympathetic
and sensory-motor nerves could be due to competition for a limited
supply of neurotrophic factors between neuronal populations innervating
a common target. Therefore, ablation of any of the two neuronal
populations may result in marked terminal proliferation in the
remaining neurons. However, although neonatal sympathectomy is
consistently associated with increased levels of sensory-motor
innervation, after sensory-motor denervation both an increase of and a
lack of changes in sympathetic innervation have been described in
different tissues. This discrepancy between no change and an increase
in sympathetic innervation in the heart and tarsal muscle (this study;
Fike et al., 1992
) and in the vasculature (Terenghi et
al., 1986
; Luthman et al., 1989
; Ralevic et
al., 1995a
) after sensory-motor denervation may be explained by
the fact that an enrichment of sympathetic innervation may not be evidenced in tissues highly supplied with sympathetic nerves, such as
myocardium and skeletal muscle, whereas it is observed in the
relatively less densely innervated blood vessels.
Furthermore, the present results lead us to speculate that sympathectomy and sensory-motor denervation are associated with patterns of reinnervation not only based on the availability of neurotrophic factors in the target tissue but also determined by function. Our previous studies have shown hyperinnervation of atrial tissue by sensory-motor nerves after neonatal sympathectomy, which implies a larger release of CGRP within the myocardium. In these conditions, not only does the peripheral activity of capsaicin-sensitive nerves represent the local motor response to the activation of sensory-mediated reflexes, but it might also provide compensatory cardioexcitatory actions by peripheral release of CGRP when the tissue content of norepinephrine is reduced. The converse does not apply, because sympathetic nerves are unable to compensate for the lost efferent function provided by sensory-motor nerves and therefore do not increase. Capsaicin treatment might rather lead to a richer innervation of the myocardium by capsaicin-insensitive sensory fibers that could compensate for a variety of reflex responses normally supplied by sensory-motor nerves. In light of these observations, the present study adds new information on cardiac autonomic innervation and further support for the importance of the peripheral function of sensory-motor nerves in the autonomic control of the heart.
In addition to cardioexcitatory actions due to activation of
sensory-motor nerves, direct effects of capsaicin have recently been
described in the heart, primarily mediated by blocking of Ca++ channels (D'Alonzo et al., 1995). The
blocking of K+ ion conductance by capsaicin has also been
shown in isolated cardiac myocytes (Castle, 1992
). In the present
investigation, however, neonatal treatment with capsaicin appeared to
reduce the animals' growth without affecting the myocardial function; body weight was lower, whereas neither basal contractile tension nor
calcium-evoked inotropism differed between control and
capsaicin-treated preparations. Such a lack of direct actions of
capsaicin on the cardiac contractile machinery rules out any possible
misinterpretation of the present data as resulting from the effect of
capsaicin on body weight.
It is well documented that sympathetic denervation results in enhanced
responsiveness of most tissues, including the myocardium, to
adrenoceptor agonists (Ishii et al., 1982
; Cros and McNeil, 1987
; Rice et al., 1987
). The present study shows that
inotropic responses of atrial myocardium to the sensory-motor
transmitter CGRP were similar in control and capsaicin-treated
preparations. Neither maximal responses nor pD2 values were
significantly different after neonatal capsaicin treatment. Similar
results were obtained in the mesenteric arterial bed isolated from
capsaicin-treated rats, where vasodilator responses to CGRP did not
differ from those in control preparations (Ralevic et al.,
1995b
). The data the present investigation yielded are also consistent
with a lack of supersensitivity to CGRP in other tissues after chronic
treatment with capsaicin, as described by McEwan and co-workers (McEwan et al., 1993).
In summary, the present findings indicate that sensory-motor denervation by neonatal treatment with capsaicin does not affect cardiac sympathetic neurotransmission. Furthermore, they show that sensory-motor denervation is not associated with supersensitivity of the atrial myocardium to the sensory-motor neurotransmitter CGRP. These data will contribute to the understanding of the autonomic control of cardiac function.
| |
Acknowledgments |
|---|
The authors thank the British Heart Foundation (A.R.) and the Royal Society (V.R.) for financial support.
| |
Footnotes |
|---|
Accepted for publication April 9, 1997.
Received for publication October 8, 1996.
Send reprint requests to: Annalisa Rubino, Ph.D., Department of Anatomy and Developmental Biology, University College London, Gower Street, London WC1E 6BT, England.
| |
Abbreviations |
|---|
CGRP, calcitonin gene-related peptide; SP, substance P; EFS, electrical field stimulation.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Zanesco, S. K. P. Costa, S. R. Riado, L. P. Nathan, C. F. de Oliveira, I. M. S. De Luca, E. Antunes, and G. De Nucci Modulation of Coronary Flow and Cardiomyocyte Size by Sensory Fibers Hypertension, October 1, 1999; 34(4): 790 - 794. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||